Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment

Alexandra V. Lucs, Benjamin Saltman, Christine H. Chung, Bettie M. Steinberg, David L. Schwartz

Research output: Contribution to journalArticle

Abstract

Head and neck oncologists have traditionally relied on clinical tumor features and patient characteristics to guide care of individual patients. As surgical, radiotherapeutic, and systemic treatments have evolved to become more anatomically precise and mechanistically specific, the opportunity for improved cure and functional patient recovery has never been more promising for this historically debilitating cancer. However, personalized treatment must be accompanied by sophisticated patient selection to triage the application of advanced therapies toward ideal patient candidates. In this monograph, we review current progress, investigative themes, and key challenges facing head and neck cancer biomarker development intended to make personalized head and neck cancer treatment a clinical reality.

Original languageEnglish (US)
Pages (from-to)294-306
Number of pages13
JournalHead and Neck
Volume35
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Head and Neck Neoplasms
Biomarkers
Triage
Therapeutics
Tumor Biomarkers
Patient Selection
Neoplasms
Patient Care
Neck
Head

Keywords

  • biomarker
  • DNA damage repair
  • epidermal growth factor receptor
  • functional imaging
  • head and neck cancer
  • human papillomavirus
  • magnetic resonance imaging
  • microarray
  • noncoding RNA
  • personalized therapy
  • positron-emission tomography
  • prognosis
  • radiotherapy
  • treatment response

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Lucs, A. V., Saltman, B., Chung, C. H., Steinberg, B. M., & Schwartz, D. L. (2013). Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. Head and Neck, 35(2), 294-306. https://doi.org/10.1002/hed.21975

Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. / Lucs, Alexandra V.; Saltman, Benjamin; Chung, Christine H.; Steinberg, Bettie M.; Schwartz, David L.

In: Head and Neck, Vol. 35, No. 2, 02.2013, p. 294-306.

Research output: Contribution to journalArticle

Lucs, AV, Saltman, B, Chung, CH, Steinberg, BM & Schwartz, DL 2013, 'Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment', Head and Neck, vol. 35, no. 2, pp. 294-306. https://doi.org/10.1002/hed.21975
Lucs, Alexandra V. ; Saltman, Benjamin ; Chung, Christine H. ; Steinberg, Bettie M. ; Schwartz, David L. / Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. In: Head and Neck. 2013 ; Vol. 35, No. 2. pp. 294-306.
@article{c0d5212789f144acbc48c3928cbcb057,
title = "Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment",
abstract = "Head and neck oncologists have traditionally relied on clinical tumor features and patient characteristics to guide care of individual patients. As surgical, radiotherapeutic, and systemic treatments have evolved to become more anatomically precise and mechanistically specific, the opportunity for improved cure and functional patient recovery has never been more promising for this historically debilitating cancer. However, personalized treatment must be accompanied by sophisticated patient selection to triage the application of advanced therapies toward ideal patient candidates. In this monograph, we review current progress, investigative themes, and key challenges facing head and neck cancer biomarker development intended to make personalized head and neck cancer treatment a clinical reality.",
keywords = "biomarker, DNA damage repair, epidermal growth factor receptor, functional imaging, head and neck cancer, human papillomavirus, magnetic resonance imaging, microarray, noncoding RNA, personalized therapy, positron-emission tomography, prognosis, radiotherapy, treatment response",
author = "Lucs, {Alexandra V.} and Benjamin Saltman and Chung, {Christine H.} and Steinberg, {Bettie M.} and Schwartz, {David L.}",
year = "2013",
month = "2",
doi = "10.1002/hed.21975",
language = "English (US)",
volume = "35",
pages = "294--306",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment

AU - Lucs, Alexandra V.

AU - Saltman, Benjamin

AU - Chung, Christine H.

AU - Steinberg, Bettie M.

AU - Schwartz, David L.

PY - 2013/2

Y1 - 2013/2

N2 - Head and neck oncologists have traditionally relied on clinical tumor features and patient characteristics to guide care of individual patients. As surgical, radiotherapeutic, and systemic treatments have evolved to become more anatomically precise and mechanistically specific, the opportunity for improved cure and functional patient recovery has never been more promising for this historically debilitating cancer. However, personalized treatment must be accompanied by sophisticated patient selection to triage the application of advanced therapies toward ideal patient candidates. In this monograph, we review current progress, investigative themes, and key challenges facing head and neck cancer biomarker development intended to make personalized head and neck cancer treatment a clinical reality.

AB - Head and neck oncologists have traditionally relied on clinical tumor features and patient characteristics to guide care of individual patients. As surgical, radiotherapeutic, and systemic treatments have evolved to become more anatomically precise and mechanistically specific, the opportunity for improved cure and functional patient recovery has never been more promising for this historically debilitating cancer. However, personalized treatment must be accompanied by sophisticated patient selection to triage the application of advanced therapies toward ideal patient candidates. In this monograph, we review current progress, investigative themes, and key challenges facing head and neck cancer biomarker development intended to make personalized head and neck cancer treatment a clinical reality.

KW - biomarker

KW - DNA damage repair

KW - epidermal growth factor receptor

KW - functional imaging

KW - head and neck cancer

KW - human papillomavirus

KW - magnetic resonance imaging

KW - microarray

KW - noncoding RNA

KW - personalized therapy

KW - positron-emission tomography

KW - prognosis

KW - radiotherapy

KW - treatment response

UR - http://www.scopus.com/inward/record.url?scp=84872766598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872766598&partnerID=8YFLogxK

U2 - 10.1002/hed.21975

DO - 10.1002/hed.21975

M3 - Article

C2 - 22287320

AN - SCOPUS:84872766598

VL - 35

SP - 294

EP - 306

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 2

ER -